Selleckchem Inc

Bio Active Compounds.

Recent products

Vantictumab (Anti-FZD)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Tabituximab (Anti-FZD10)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Volagidemab (Anti-GCGR)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Naxitamab (Anti-GD2)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Dinutuximab (Anti-GD2)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Ecromeximab (Anti-GD3)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Ponsegromab (Anti-GDF15 / MIC-1)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Apitegromab (Anti-GDF8 / Myostatin)

Price range: £221.00 through £1,941.00 / 309.402,717.40 Standard

Nadecnemab (Anti-GFRA3)

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Anti-GFRAL

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Glenzocimab (Anti-GP6 / Glycoprotein-6)

Price range: £303.00 through £2,432.00 / 424.203,404.80 Standard

Anti-GPA33

Price range: £441.00 through £4,152.00 / 617.405,812.80 Standard

Codrituzumab (Anti-GPC3 / Glypican-3)

Price range: £221.00 through £1,941.00 / 309.402,717.40 Standard

Glembatumumab (Anti-GPNMB)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

Petosemtamab (Anti-GPR49 / LGR5)

Price range: £384.00 through £3,415.00 / 537.604,781.00 Standard

Talquetamab (Anti-GPRC5D)

Price range: £243.00 through £2,432.00 / 340.203,404.80 Standard

1 687 688 689 705